risk factors

  1. Chandelier

    Preventive effect of vaccination on long COVID in adolescents with SARS-CoV-2 infection, 2025, Thaweethai et al.

    https://www.sciencedirect.com/science/article/pii/S0264410X25012046 Abstract Purpose In adolescents (12–17 years), it is unknown whether COVID-19 vaccination reduces progression from COVID-19 to Long COVID (LC) beyond preventing SARS-CoV-2 infection. We assessed the effect of vaccination...
  2. SNT Gatchaman

    Exploring predictors of post-COVID-19 condition among 810 851 individuals in Sweden, 2025, Xu et al.

    Exploring predictors of post-COVID-19 condition among 810 851 individuals in Sweden BACKGROUND Long-term effects of COVID-19 can place burden on individuals, healthcare, and society. We aimed to evaluate the importance of a wide range of potential risk factors for being diagnosed with...
  3. SNT Gatchaman

    Schizophrenia, Bipolar, or Major Depressive Disorder and Postacute Sequelae of COVID-19, 2025, Vekaria et al.

    Schizophrenia, Bipolar, or Major Depressive Disorder and Postacute Sequelae of COVID-19 IMPORTANCE Given the increased vulnerability to COVID-19 among those with a serious mental illness (SMI), it remains unclear whether these individuals face a higher risk of developing postacute sequelae of...
  4. SNT Gatchaman

    Pre-pandemic disease trajectories and genetic insights into long COVID susceptibility, 2025, Blay et al.

    Pre-pandemic disease trajectories and genetic insights into long COVID susceptibility BACKGROUND Long COVID refers to the persistence of symptoms after SARS-CoV-2 infection. While individual comorbidities have been studied, the role of coexisting chronic conditions remains underexplored. This...
  5. Chandelier

    Prevalence of post COVID-19 condition and associations with risk factors among U.S. adults: 2023 Behavioral Risk Factor Surveillance System,2025,Heath

    https://pubmed.ncbi.nlm.nih.gov/41080863/ Abstract Introduction: During the COVID-19 pandemic, between 12 and 20% of US adults were identified as having post-COVID-19 condition, commonly referred to as 'Long COVID'. These individuals maintained symptoms of COVID-19 for 3 months or longer...
  6. SNT Gatchaman

    Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis, 2025, Pukaj et al.

    Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis BACKGROUND AND OBJECTIVES Intrathecal synthesis of immunoglobulin G (IgG) is a key feature of multiple sclerosis (MS) and a prognostic marker for the disease course. Although previous...
  7. SNT Gatchaman

    Long COVID After Acquisition of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2 During Pregnancy Compared With Outsi

    Long COVID After Acquisition of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2 During Pregnancy Compared With Outside of Pregnancy OBJECTIVE To evaluate whether the risk of long COVID among individuals infected with severe acute respiratory syndrome...
  8. SNT Gatchaman

    Associations of selective serotonin reuptake inhibitors and long COVID risk in patients with depression: a retrospective cohort study, 2025, Gao et al

    Associations of selective serotonin reuptake inhibitors and long COVID risk in patients with depression: a retrospective cohort study PURPOSE To evaluate the potential of selective serotonin reuptake inhibitors (SSRIs) in reducing the risk of long COVID in patients with depression. METHODS...
  9. SNT Gatchaman

    Preprint Incidence of Long COVID Following Reinfection with COVID-19, 2025, Brannock et al.

    Incidence of Long COVID Following Reinfection with COVID-19 M Daniel Brannock; Emily Hadley; Alexander Preiss; Megan L Fitzgerald; Nita Jain; Emily Taylor; Andrew Wylam; Yun J Yoo; Elaine Hill; Richard A Moffitt; N3C Consortium; RECOVER Consortium BACKGROUND COVID-19 reinfections have emerged...
  10. SNT Gatchaman

    Pre-COVID health-related quality of life predicts symptoms and outcomes for patients with long COVID, 2025, Lapin et al.

    Pre-COVID health-related quality of life predicts symptoms and outcomes for patients with long COVID Lapin, Brittany; Baker, Samantha; Thompson, Nicolas; Li, Yadi; Milinovich, Alex; Lago, William; Katzan, Irene BACKGROUND Post-acute sequelae SARS-CoV-2 (PASC) is a prevalent condition with...
  11. SNT Gatchaman

    Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort, 2025, Feldman et al.

    Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort BACKGROUND Social determinants of health (SDoH) contribute to disparities in SARS-CoV-2 infection, but their associations with long COVID are unknown. OBJECTIVE To determine associations between SDoH at the...
  12. J

    Elevated risk of new-onset chronic fatigue syndrome/myalgic encephalomyelitis up to four years after SARS-CoV-2 infection 2025 Hadidchi et al.

    Background Fatigue is a common sequela of SARS-CoV-2 infection, with many COVID-19 patients subsequently developing chronic fatigue syndrome and myalgic encephalomyelitis (CFS/ME). Long-term associations between COVID-19, new-onset CFS/ME, and other independent predictors such as vaccination for...
  13. SNT Gatchaman

    Decreased risk of chronic fatigue syndrome following influenza vaccine: a 20-year population-based retrospective study, 2025, Chang et al.

    Decreased risk of chronic fatigue syndrome following influenza vaccine: a 20-year population-based retrospective study Chang, Hsun; Yao, Wei-Cheng; Yu, Teng-Shun; Lin, Heng-Jun; Tsai, Fuu-Jen; Ho, Shinn-Ying; Kuo, Chien-Feng; Tsai, Shin-Yi BACKGROUND Chronic Fatigue Syndrome (CFS) is a...
  14. SNT Gatchaman

    Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms, 2025, Yukari Magawa et al.

    Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms Yukari Magawa, Jhosiene; Jacintho, Lucas Cauê; Alves Ferreira, Marcelo; Ramos Oliveira, Jamille; Rahal Guaragna Machado, Rafael; Kuramoto Takara, Andreia; Moreno Lima de Oliveira, Renata...
  15. SNT Gatchaman

    Increased Risk of Post-Acute Sequalae of COVID-19 in Patients With Immune-Mediated Inflammatory Diseases, 2025, Vitus et al.

    Increased Risk of Post-Acute Sequalae of COVID-19 in Patients With Immune-Mediated Inflammatory Diseases Evangelin Shaloom Vitus; Christian Nikolai Sørensen; Anastasia Karachalia Sandri; Rahma Elmahdi; Tine Jess BACKGROUND AND AIMS Dysregulation of the immune system and chronic inflammation...
  16. Hutan

    Prevalence and severity of neurologic symptoms in Long-COVID, pre-existing conditions, hospitalization, mental health, 2025, Huff, Nath, Walitt +

    Hanalise Huff, Henry Roberts, Elizabeth Bartrum, Gina Norato, Nicholas Grayson, Katherine Fleig, Miciah Wilkerson, Barbara Stussman, Avindra Nath, Brian Walitt* Background: Long-COVID refers to ongoing, relapsing, or new symptoms present 30 or more days after Severe Acute Respiratory...
  17. forestglip

    Symptom Burden and Post-COVID-19 Syndrome 24 Months Following SARS-CoV-2 Infection: Longitudinal Population-Based Study, 2025, Peter et al

    Symptom Burden and Post-COVID-19 Syndrome 24 Months Following SARS-CoV-2 Infection: Longitudinal Population-Based Study Raphael S. Peter, Lisamaria Eble, Alexandra Nieters, Stefan O. Brockmann, Siri Göpel, Uta Merle, Jürgen M. Steinacker, Hans-Georg Kräusslich, Dietrich Rothenbacher, Winfried...
  18. forestglip

    Preprint Impact of COVID 19 Vaccination on Long COVID Symptoms in Ecuador a Nationwide Cross Sectional Study, 2025, Loaiza et al

    Impact of COVID 19 Vaccination on Long COVID Symptoms in Ecuador a Nationwide Cross Sectional Study Santiago Israel Bravo Loaiza, Heon-Jae Jeong, Se Eun Park, Tania Veronica Cabrera Parra, Sunjoo Kang Background Long COVID is a growing concern, necessitating preventive strategies like...
  19. Dolphin

    Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents, 2025, Wu

    https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00541-8/fulltext Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents Qiong Wu Bingyu Zhang Jiayi Tong L. Charles Bailey H. Timothy Bunnell Jiajie Chen b,c ∙ et al...
  20. forestglip

    A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States, 2025, Daniel Kim

    A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States Daniel Kim Background In the United States, concerns have been increasingly raised over the future public health and economic burden of long COVID including disability and...
Back
Top Bottom